Relationships between plasma fatty acid composition and coronary artery disease

Journal of Atherosclerosis and Thrombosis

Volumn 18, Issue 2, 2011, Pages 99-107

  Itakura, Hiroshige ^a   Yokoyama, Mitsuhiro ^b   Matsuzaki, Masunori ^c   Saito, Yasushi ^d   Origasa, Hideki ^e   Ishikawa, Yuichi ^f   Oikawa, Shinichi ^g   Sasaki, Jun ^h   Hishida, Hitoshi ⁱ   Kita, Toru ^j   Kitabatake, Akira ^k   Nakaya, Noriaki ^l   Sakata, Toshiie ^m   Shimada, Kazuyuki ⁿ   Shirato, Kunio ^o   Matsuzawa, Yuji ^p  

^a Shinagawa East One Medical Clinic   (Japan)

^b HYOGO PREFECTURAL AWAJI HOSPITAL   (Japan)

^c YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d CHIBA UNIVERSITY   (Japan)

^e UNIVERSITY OF TOYAMA   (Japan)

^f Kakogawa Municipal Hospital   (Japan)

^g NIPPON MEDICAL SCHOOL   (Japan)

^h INTERNATIONAL UNIVERSITY OF HEALTH AND WELFARE   (Japan)

ⁱ FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^j KOBE CITY MEDICAL CENTER GENERAL HOSPITAL   (Japan)

^k Hiraoka Hospital   (Japan)

^l Nakaya Clinic   (Japan)

^m Hisatsune Hospital   (Japan)

ⁿ JICHI MEDICAL UNIVERSITY   (Japan)

^o Saito Hospital   (Japan)

^p SUMITOMO HOSPITAL   (Japan)

more..

Author keywords

Coronary heart disease; Docosahexaenoic acid; Eicosapentaenoic acid; Lipoprotein

Indexed keywords

ARACHIDONIC ACID; DIHOMO GAMMA LINOLENIC ACID; DOCOSAHEXAENOIC ACID; DOCOSAPENTAENOIC ACID; FATTY ACID; GAMMA LINOLENIC ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ICOSAPENTAENOIC ACID; LINOLEIC ACID; LINOLENIC ACID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MYRISTIC ACID; OLEIC ACID; PALMITIC ACID; PALMITOLEIC ACID; PRAVASTATIN; SIMVASTATIN; STEARIC ACID;

ADULT; AGED; ANGIOPLASTY; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; FATTY ACID BLOOD LEVEL; FEMALE; HEART INFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; LIPID COMPOSITION; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SUDDEN DEATH; TRIACYLGLYCEROL BLOOD LEVEL; UNSTABLE ANGINA PECTORIS;

EID: 79952397333     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.5876     Document Type: Article

References (32)

1. Wolfram G: Dietary fatty acids and coronary heart disease. Eur J Med Res, 2003; 8: 321-324
2. Yamamoto A, Richie G, Nakamura H, Hosoda S, Nobuyoshi M, Matsuzaki M, Tan CE, Keech A, Mabuchi H, Horibe H, Tenba H: Risk factors for coronary heart disease in the Japanese--comparison of the background of patients with acute coronary syndrome in the ASPAC study with data obtained from the general population. Asia-Pacific Collaboration on CHD Risk Factor Intervention study. J Atheroscler Thromb, 2002; 9: 191-199
3. Harris WS: The omega-6/omega-3 ratio and cardiovascular disease risk: uses and abuses. Curr Atheroscler Rep, 2006; 8: 453-459
4. Arai H, Yamamoto A, Matsuzawa Y, Saito Y, Yamada N, Oikawa S, Mabuchi H, Teramoto T, Sasaki J, Nakaya N, Itakura H, Ishikawa Y, Ouchi Y, Horibe H, Shirahashi N, Kita T: Prevalence of metabolic syndrome in the general Japanese population in 2000. J Atheroscler Thromb, 2006; 13: 202-208
5. Gruppo Italiano per lo Studio della Sopravvivenza nell' Infarto miocardico: Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet, 1999; 354: 447-455
6. Marchioli R, Barzi F, Bomba E, Chieffo C, Di Gregorio D, Di Mascio R, Franzosi MG, Geraci E, Levantesi G, Maggioni AP, Mantini L, Marfisi RM, Mastrogiuseppe G, Mininni N, Nicolosi GL, Santini M, Schweiger C, Tavazzi L, Tognoni G, Tucci C, Valagussa F: Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation, 2002; 105: 1897-1903
7. Harris WS, Von Schacky C: The Omega-3 Index: a new risk factor for death from coronary heart disease? Prev Med, 2004; 39: 212-220
8. Leskinen MH, Solakivi T, Kunnas T, Alho H, Nikkari ST: Serum fatty acids in postinfarction middle-aged men. Scand J Clin Lab Invest, 2005; 65: 485-490
9. Yli-Jama P, Meyer HE, Ringstad J, Pedersen JI: Serum free fatty acid pattern and risk of myocardial infarction: a casecontrol study. J Intern Med, 2002; 251: 19-28
10. Kark JD, Manor O, Goldman S, Berry EM: Stability of red blood cell membrane fatty acid composition after acute myocardial infarction. J Clin Epidemiol, 1995; 48: 889-895
11. Luostarinen R, Boberg M, Saldeen T: Fatty acid composition in total phospholipids of human coronary arteries in sudden cardiac death. Atherosclerosis, 1993; 99: 187-193
12. Yokoyama M, Origasa H: Effects of eicosapentaenoic acid on cardiovascular events in Japanese patients with hypercholesterolemia: rationale, design, and baseline characteristics of the Japan EPA Lipid Intervention Study (JELIS). Am Heart J, 2003; 146: 613-620
13. Yokoyama M, Origasa H, Matsuzaki M, Matsuzawa Y, Saito Y, Ishikawa Y, Oikawa S, Sasaki J, Hishida H, Itakura H, Kita T, Kitabatake A, Nakaya N, Sakata T, Shimada K, Shirato K: Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet, 2007; 369: 1090-1098
14. Oliver MF: National cholesterol policies. Eur Heart J, 1993; 14: 581-583
15. James MJ, Gibson RA, Cleland LG: Dietary polyunsaturated fatty acids and inflammatory mediator production. Am J Clin Nutr, 2000; 71: 343S-348S
16. Nakamura Y, Ueshima H, Okamura T, Kadowaki T, Hayakawa T, Kita Y, Tamaki S, Okayama A: Association between fish consumption and all-cause and cause-specific mortality in Japan: NIPPON DATA80, 1980-99. Am J Med, 2005; 118: 239-245
17. Iso H, Kobayashi M, Ishihara J, Sasaki S, Okada K, Kita Y, Kokubo Y, Tsugane S; JPHC Study Group: Intake of fish and n3 fatty acids and risk of coronary heart disease among Japanese: the Japan Public Health Center-Based (JPHC) Study Cohort I. Circulation, 2006; 17: 195-202
18. Yanagisawa N, Shimada K, Miyazaki T, Kume A, Kitamura Y, Ichikawa R, Ohmura H, Kiyanagi T, Hiki M, Fukao K, Sumiyoshi K, Hirose K, Matsumori R, Takizawa H, Fujii K, Mokuno H, Inoue N, Daida H: Polyunsaturated fatty acid levels of serum and red blood cells in apparently healthy Japanese subjects living in an urban area. J Atheroscler Thromb, 2010; 17: 285-294
19. Zhao Y, Joshi-Barve S, Barve S, Chen LH: Eicosapentaenoic acid prevents LPS-induced TNF-alpha expression by preventing NF-kappaB activation. J Am Coll Nutr, 2004; 23: 71-78
20. Serhan CN: Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways. Annu Rev Immunol, 2007; 25: 101-137
21. Schwab JM, Chiang N, Arita M, Serhan CN: Resolvin E1 and protectin D1 activate inflammation-resolution programmes. Nature, 2007; 447: 869-874
22. Arita M, Bianchini F, Aliberti J, Sher A, Chiang N, Hong S, Yang R, Petasis NA, Serhan CN: Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1. J Exp Med, 2005; 201: 713-722
23. Dona M, Fredman G, Schwab JM, Chiang N, Arita M, Goodarzi A, Cheng G, von Andrian UH, Serhan CN: Resolvin E1, an EPA-derived mediator in whole blood, selectively counterregulates leukocytes and platelets. Blood, 2008; 112: 848-855
24. Matsumoto M, Sata M, Fukuda D, Tanaka K, Soma M, Hirata Y, Nagai R: Orally administered eicosapentaenoic acid reduces and stabilizes atherosclerotic lesions in ApoEdeficient mice. Atherosclerosis, 2008; 197: 524-533
25. Jia Y, Turek JJ: Altered NF-kappaB gene expression and collagen formation induced by polyunsaturated fatty acids. J Nutr Biochem, 2005; 16: 500-506
26. Leaf A, Albert CM, Josephson M, Steinhaus D, Kluger J, Kang JX, Cox B, Zhang H, Schoenfeld D: Prevention of fatal arrhythmias in high-risk subjects by fish oil n-3 fatty acid intake. Circulation, 2005; 112: 2762-2768
27. Terano T, Hirai A, Hamazaki T, Kobayashi S, Fujita T, Tamura Y, Kumagai A: Effect of oral administration of highly purified eicosapentaenoic acid on platelet function, blood viscosity and red cell deformability in healthy human subjects. Atherosclerosis, 1983; 46: 321-331
28. Hirai A, Terano T, Makuta H, Ozawa A, Fujita T, Tamura Y, Yoshida S: Effect of oral administration of highly purified eicosapentaenoic acid and docosahexaenoic acid on platelet function and serum lipids in hyperlipidemic patients. Adv Prostaglandin Thromboxane Leukot Res, 1989; 19: 627-630
29. Terano T, Shiina T, Tamura Y: Eicosapentaenoic acid suppressed the proliferation of vascular smooth muscle cells through modulation of various steps of growth signals. Lipids, 1996; 31 Suppl: S301-304
30. Nomura S, Shouzu A, Omoto S, Inami N, Ueba T, Urase F, Maeda Y: Effects of eicosapentaenoic acid on endothelial cell-derived microparticles, angiopoietins and adiponectin in patients with type 2 diabetes. J Atheroscler Thromb, 2009; 16: 83-90
31. Nozaki S, Matsuzawa Y, Hirano K, Sakai N, Kubo M, Tarui S: Effects of purified eicosapentaenoic acid ethyl ester on plasma lipoproteins in primary hypercholesterolemia. Int J Vitam Nutr Res, 1992; 62: 256-260
32. Thies F, Garry JM, Yaqoob P, Rerkasem K, Williams J, Shearman CP, Gallagher PJ, Calder PC, Grimble RF: Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial. Lancet, 2003; 361: 477-485